Sun Pharmaceutical Industries Ltd. closed 10.55% below its 52-week high of 1,960.20 rupees, which the company reached on ...

Here are the complete details of companies whose shares will trade ex-date tomorrow, along with their corporate announcements ...

The patent refers to SciSparc’s innovative combination therapy of N-Acylethanolamines and Clearmind’s MEAI, (5-methoxy-2-aminoindane) addressing binge behaviour, including alcohol consumption, eating, ...

The next generation has been entrusted with more responsibility at the family-run Sun Pharma, India’s largest drug maker, and ...

Sun Pharma has announced the Company has designated Aalok Shanghvi - Whole-time Director and Executive Vice-President, ...

Sun Pharma has promoted Aalok Shanghvi to Chief Operating Officer. Previously a Whole-time Director, Shanghvi has been with the company since 2006. Known for his diverse role experience, he has ...

Sun Pharmaceutical Industries has elevated Aalok Shanghvi, son of MD Dilip Shanghvi, as its new Chief Operating Officer.

Sun Pharma appoints Aalok Shanghvi as COO, overseeing global operations and R&D, with expertise in emerging markets.

Sun Pharma on Monday said it has elevated Aalok Shanghvi as Chief Operating Officer.He is currently designated as Whole-time Director and Executive ...

The pharmaceutical business Sun Pharma held the meeting on January 31, 2025. The company announced the record date and ...

Sun Pharmaceutical Industries reported a 15 percent on-year increase in consolidated net profit, reaching Rs 2,903 crore for ...

While Sun Pharma continues to demonstrate strength in its branded and specialty businesses, concerns around US generics, R&D ...